BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Archives
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • September 2024
  • August 2024
  • July 2024
  • May 2024
  • April 2024
  • December 2023
  • October 2023
  • August 2023
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • December 2021
  • November 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Subscribe

ImageneBio (IMA) Targets 3,634% Upside

    ImageneBio Inc. (NASDAQ:IMA) is a clinical-stage biopharmaceutical company dedicated to…
    BioTech Health X
    • October 26, 2025
    0 Shares
    0
    0
    0
    0
    0
    0
    0

    4D Molecular Therapeutics (FDMT) Price Target Signals 176% Upside

    • BioTech Health X
    • October 26, 2025

    Neumora Therapeutics (NMRA) Backed by Amgen with 22% Stake

    • BioTech Health X
    • October 26, 2025

    Euda Health (EUDA) Launches Strategic India Partnership

    • BioTech Health X
    • October 26, 2025

    Kyverna (KYTX) Could Become the 1st $10B Autoimmune CAR T Company

    • BioTech Health X
    • October 26, 2025

    Most Trending
    Stories

    Biotech NewsImageneBio (IMA) Targets 3,634% Upside

    • BioTech Health X
    • October 26, 2025

    Biotech News4D Molecular Therapeutics (FDMT) Price Target Signals 176% Upside

    • BioTech Health X
    • October 26, 2025

    Biotech NewsNeumora Therapeutics (NMRA) Backed by Amgen with 22% Stake

    • BioTech Health X
    • October 26, 2025

    Biotech NewsEuda Health (EUDA) Launches Strategic India Partnership

    • BioTech Health X
    • October 26, 2025

    Biotech NewsKyverna (KYTX) Could Become the 1st $10B Autoimmune CAR T Company

    • BioTech Health X
    • October 26, 2025

    ImageneBio (IMA) Targets 3,634% Upside

    • BioTech Health X
    • October 26, 2025
    ImageneBio Inc. (NASDAQ:IMA) is a clinical-stage biopharmaceutical company dedicated to developing next-generation therapies for immunological and inflammatory diseases…
    Read More
    0 Shares
    0
    0
    0
    0
    0
    0
    0

    4D Molecular Therapeutics (FDMT) Price Target Signals 176% Upside

    • BioTech Health X
    • October 26, 2025
    4D Molecular Therapeutics Inc. (NASDAQ:FDMT) is a clinical-stage biopharmaceutical company pioneering a new generation of genetic medicines through…
    Read More
    0 Shares
    0
    0
    0
    0
    0
    0
    0

    Neumora Therapeutics (NMRA) Backed by Amgen with 22% Stake

    • BioTech Health X
    • October 26, 2025
    Neumora Therapeutics Inc. (NASDAQ:NMRA) is a clinical-stage biotechnology company singularly focused on transforming the treatment of brain diseases…
    Read More
    0 Shares
    0
    0
    0
    0
    0
    0
    0

    Euda Health (EUDA) Launches Strategic India Partnership

    • BioTech Health X
    • October 26, 2025
    Euda Health Holdings Limited (NASDAQ:EUDA) is a Singapore-based healthcare technology company focused on transforming the delivery of preventive…
    Read More
    0 Shares
    0
    0
    0
    0
    0
    0
    0

    Kyverna (KYTX) Could Become the 1st $10B Autoimmune CAR T Company

    • BioTech Health X
    • October 26, 2025
    Kyverna Therapeutics Inc. (NASDAQ:KYTX) is a clinical-stage biopharmaceutical company focused on transforming the treatment paradigm for autoimmune diseases…
    Read More
    0 Shares
    0
    0
    0
    0
    0
    0
    0

    Creative Medical (CELZ) Narrows Loss by 21% and Shares Jump 14%

    • BioTech Health X
    • October 26, 2025
    Creative Medical Technology Holdings Inc. (NASDAQ:CELZ) is a clinical-stage biotechnology company pioneering breakthrough regenerative medicine and cell-based technologies…
    Read More
    0 Shares
    0
    0
    0
    0
    0
    0
    0

    Gossamer Bio (GOSS) Targets $7 Billion PAH Market

    • BioTech Health X
    • October 26, 2025
    Gossamer Bio Inc. (NASDAQ:GOSS) is a clinical-stage biopharmaceutical company founded with a mission to develop breakthrough therapies targeting…
    Read More
    0 Shares
    0
    0
    0
    0
    0
    0
    0

    Clover Health (CLOV) Surges 19% After Buy Rating

    • BioTech Health X
    • October 26, 2025
    Clover Health Investments Corp. (NASDAQ:CLOV) is a next-generation health technology company transforming the U.S. healthcare system through its…
    Read More
    0 Shares
    0
    0
    0
    0
    0
    0
    0

    180 Life Sciences (ATNF) Acquires 82K ETH After $425M Raise

    • BioTech Health X
    • October 26, 2025
    180 Life Sciences Corp. (NASDAQ:ATNF) is a formerly clinical-stage biotechnology company that has strategically transformed its business model…
    Read More
    0 Shares
    0
    0
    0
    0
    0
    0
    0

    Syndax (SNDX) Surges 40.5% in 3 Months

    • BioTech Health X
    • October 26, 2025
    Syndax Pharmaceuticals Inc. (NASDAQ:SNDX) is a clinical and now commercial-stage biopharmaceutical company committed to developing and delivering transformative…
    Read More
    0 Shares
    0
    0
    0
    0
    0
    0
    0

    Armata Pharma (ARMP) Skyrockets 103% in One Day

    • BioTech Health X
    • October 26, 2025
    Armata Pharmaceuticals Inc. (NYSE:ARMP) is a clinical-stage biotechnology company focused on pioneering bacteriophage-based therapeutics, a groundbreaking approach to…
    Read More
    0 Shares
    0
    0
    0
    0
    0
    0
    0

    Genprex (GNPX) Raises $2.7M to Accelerate FDA Fast Track Trials

    • BioTech Health X
    • October 26, 2025
    Genprex Inc. (NASDAQ:GNPX) is a clinical-stage gene therapy company headquartered in Austin, Texas, focused on developing transformative, potentially…
    Read More
    0 Shares
    0
    0
    0
    0
    0
    0
    0

    Hedge Funds Are Quietly Loading Up on Neuphoria (NEUP)

    • BioTech Health X
    • October 26, 2025
    Neuphoria Therapeutics Inc. (NASDAQ:NEUP) is a clinical-stage biotechnology company focused on developing next-generation treatments for neuropsychiatric disorders through…
    Read More
    0 Shares
    0
    0
    0
    0
    0
    0
    0

    Genenta Science (GNTA) Surges 91%!!!

    • BioTech Health X
    • October 26, 2025
    Genenta Science S.p.A. (NASDAQ:GNTA) is a clinical-stage biotechnology company headquartered in Milan, Italy, pioneering a breakthrough approach to…
    Read More
    0 Shares
    0
    0
    0
    0
    0
    0
    0

    Inhibrx (INBX) Surges After Ozekibart Cuts Cancer Progression Risk by 52%

    • BioTech Health X
    • October 26, 2025
    Inhibrx Inc. (NASDAQ:INBX) is a clinical-stage biopharmaceutical company focused on developing a new generation of therapeutic candidates designed…
    Read More
    0 Shares
    0
    0
    0
    0
    0
    0
    0

    Addex Therapeutics (ADXN) is on the Brink of a Breakout

    • BioTech Health X
    • October 26, 2025
    Addex Therapeutics Ltd. (NASDAQ:ADXN) is a clinical-stage biopharmaceutical company based in Geneva, Switzerland, specializing in the discovery and…
    Read More
    0 Shares
    0
    0
    0
    0
    0
    0
    0

    Picard Medical (PMED) Plunges 59.77% in One Day

    • BioTech Health X
    • October 26, 2025
    Picard Medical Inc. (NASDAQ:PMED) is an emerging medical technology company focused on transforming the treatment landscape for men’s…
    Read More
    0 Shares
    0
    0
    0
    0
    0
    0
    0

    Coya Therapeutics (COYA) Could Be the Next 5X Biotech

    • BioTech Health X
    • October 26, 2025
    Coya Therapeutics Inc. (NASDAQ:COYA) is a clinical-stage biotechnology company pioneering a new class of therapies designed to harness…
    Read More
    0 Shares
    0
    0
    0
    0
    0
    0
    0
    Recent Posts
    • ImageneBio (IMA) Targets 3,634% Upside
    • 4D Molecular Therapeutics (FDMT) Price Target Signals 176% Upside
    • Neumora Therapeutics (NMRA) Backed by Amgen with 22% Stake
    • Euda Health (EUDA) Launches Strategic India Partnership
    • Kyverna (KYTX) Could Become the 1st $10B Autoimmune CAR T Company
    Recent Comments
    • Novavax Announces Robust First Quarter 2024 Results and Strategic Partnerships • BioTech Health X on Novavax and Sanofi Forge $1.2 Billion Alliance to Boost COVID and Flu Vaccine Efforts
    • Thomas Shentz on Cellarity Expands Leadership Team to Continue Evolution of Breakthrough Platform to Encode Biology and Purposefully Create New Drugs
    • Tomasz Michałowski on Exclusive: Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future
    • Presenters Announced for 2021 William Blair Biotech Conference • BioTech Health X on William Blair Biotech Focus Conference 2021 Panel Schedule
    Featured Posts
      • October 26, 2025
      ImageneBio (IMA) Targets 3,634% Upside
      • October 26, 2025
      4D Molecular Therapeutics (FDMT) Price Target Signals 176% Upside
      • October 26, 2025
      Neumora Therapeutics (NMRA) Backed by Amgen with 22% Stake
      • October 26, 2025
      Euda Health (EUDA) Launches Strategic India Partnership
      • October 26, 2025
      Kyverna (KYTX) Could Become the 1st $10B Autoimmune CAR T Company
    Recent Posts
    • Teladoc Health (TDOC) Posts $626.4M in Quarterly Revenue
      • October 26, 2025
    • Sagimet Biosciences (SGMT) Set for 273% Surge After Buy Rating
      • October 26, 2025
    • X4 Pharma (XFOR) Targets 44% Annual Growth as Analysts See Upside
      • October 20, 2025
    Categories
    • BioTech CEO Interviews (9)
    • Biotech Info (3)
    • Biotech News (509)
    • Uncategorized (1)
    Author
    Hello, I’m
    BioTech Health X
    Follow
    BioTech Health X
    Designed & Developed by BioTech Health X
    • About BioTech Health X
    • List of Modern Life Science Technologies
    • Biotechnology Company Directory – List of Major Biotech Companies
    • Contact Us
    • Privacy Policy

    Subscribe to
    Our Updates

    Back to top